Join
Live feed
·
PRReleasevia Quantisnow
AIkido Pharma Inc. logo

AIkido Pharma Files Patent Application for the Use of Ketamine to Treat Alzheimer's Disease

ByQuantisnow·Wall Street's wire, on your screen.
AIKI· AIkido Pharma Inc.
Consumer Discretionary

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AIKI (AIkido Pharma Inc.) and more on Quantisnow.